Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by
Read MoreThe deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by
Read MoreDanuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection
Read MoreLONDON Obesity is on track to become a major health issue for British people, with 60% of men and 50%
Read MoreOne in every three Turks clinically obese: Report Hurriyet Daily News Source link
Read More